Records containing: Malignant Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-06-25Randomised Clinical Trial of Surgery Versus Surgery Plus Adjuvant Radiotherapy for Regional Control in Patients With Completely Resected Macroscopic Nodal Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2013-05-27A Phase II Study Using Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Lymphocyte Depleting Regimen in Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2013-01-16Pilot Study of Intradermal Vaccination of Melanoma Patients With a Fixed Combination of mRNAs Compared to an Individualized Selection After Analysis of Antigen Expression in Tumor Tissue
-
CLINICAL_TRIALS study record update · 2013-01-16Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28
-
CLINICAL_TRIALS study record update · 2012-10-16ClinicalTrials.gov study NCT00862914
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2012-09-07A Phase III Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus Physician's Choice Including Interleukin-2 and/or Dacarbazine/Temozolomide-based Therapy and/or Complete Tumor Resection in Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2012-06-07Phase I/II Study Using a Non-Myeloablative Lymphocyte Depleting Regimen of Chemotherapy Followed by Infusion of Allogeneic Tumor-Reactive Lymphocyte Cell Line DMF5 in Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2012-06-06Phase 1 Open Label, Non-Randomized, Dose Escalation Study To Evaluate The Safety, Tolerability, Pharmacokinetics, Immune Function Effects, And Efficacy Of Multiple Doses Of CP-675,206 In Patients With Advanced Melanoma, And Phase 2, Open Label, Randomized Study To Evaluate the Efficacy, Safety, Tolerability And Pharmacokinetics Of 2 Regimens Of CP-675,206 In Patients With Advanced Melanoma.
-
CLINICAL_TRIALS study record update · 2012-05-03A Phase II Trial OF Carboplatin, ABI-007 (Abraxane) And Sorafenib (BAY 43-9006) in Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2012-05-03Multicenter Phase II Trial of High-Dose Interleukin (IL-2) With Priming and Concomitant Sargramostim (GM-CSF) in Patients With Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2012-03-14Phase I Study of the Tumor Saturation and Biological Activity of MEDI-522 (Abergrin), a Humanized Monoclonal Antibody Directed Against the Human Alpha V Beta 3 Integrin, in Patients With Advanced Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2012-01-05An Evaluation of the Pharmacokinetic Profile of VSLI (Vincristine Sulfate Liposome Injection, 0.16 mg/mL) in Patients With Malignant Melanoma and Hepatic Dysfunction Secondary to Metastases
-
CLINICAL_TRIALS study record update · 2011-12-22An Open-label Multicenter Study on the Efficacy of Continuous Oral Dosing of Vemurafenib on Tumour Response in Previously Treated Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2011-11-16BRIM 3: A Randomized, Open-Label, Controlled, Multicenter, Phase III Study in Previously Untreated Patients With Unresectable Stage IIIC or Stage IV Melanoma With V600E BRAF Mutation Receiving Vemurafenib (RO5185426) or Dacarbazine
-
CLINICAL_TRIALS study record update · 2011-10-17Phase II Study of CP-461 in the Treatment of Patients With Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2011-08-11Can Fibrin Sealant be Used to Reduce Post-operative Drainage Following Lymph Node Dissection: a Prospective Randomised Double Blind Trial.
-
CLINICAL_TRIALS study record update · 2011-07-07A Phase II Study of High-Dose Allovectin-7® in Patients With Advanced Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2010-11-15Safety, Tolerability, and Immunogenicity of CYT004-MelQbG10 Vaccine With or Without Immunostimulating Adjuvant in HLA-A2 Positive Patients With Stage III/IV Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2010-10-18A Survey to Assess the Incidence and Characteristics of Melanoma in Parkinson's Disease Patients
-
CLINICAL_TRIALS study record update · 2010-09-15A Phase 1/2 Trial of Amplimexon® (Imexon, Inj.) Plus Dacarbazine (DTIC) in Chemotherapy Naive Patients With Unresectable Stage III or Stage IV Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2010-08-11An International, Multicenter, Prospective, Non-controlled, Non-randomised, Clinical Study to Collect Impedance Data of Potentially Malignant Pigmented Nevi and Histological Diagnoses
-
CLINICAL_TRIALS study record update · 2010-06-25Side-effect Management for Patients With Malignant Melanoma Undergoing Treatment With Interferon Alpha (IFN-α)- Diagnosis and Therapy -
-
CLINICAL_TRIALS study record update · 2010-04-26An Open-Label Pharmacokinetic and Safety Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2010-04-09Phase I Study of gp75 DNA Vaccine in Patients With AJCC Stage III and IV Melanoma
-
CLINICAL_TRIALS study record update · 2010-02-05A Multi-centre, Two-arm, Randomized, Open, Phase II Study Investigating SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma